Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: UNIVERSITY OF OKLAHOMA
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-08-05 to 2026-02-04
Current total value of award: $1435788
Description: TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE